News

Articles

The research collaboration between AstraZeneca and VaxEquity aims to discover and develop self-amplifying RNA therapeutics.

AstraZeneca Enters into Research Collaboration With VaxEquity

CPC’s MicroCNX Series Connectors provide an alternative to tube welding at small tubing sizes.

New Sterile Connectors for Small-Bore Tubing Offer an Alternative to Welding

The joint venture with OSTHUS will expand PharmaLex’s IT consulting and system integration expertise.

PharmaLex Completes Joint Venture With OSTHUS Services

AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.

AGC Bio Boosts Manufacturing Capacity for pDNA and mRNA at Heidelberg Facility

Vector Laboratories has completed a $124 million cash buyout backed by Thompson Street Capital Partners and will begin an acquisition strategy to expand protein detection capabilities.

Vector Laboratories Closes $124 Million Buyout

Ardena acquires Idifarma, adding spray drying technology and high potency capabilities.

Ardena Acquires Idifarma From Suanfarma

AstraZeneca and the European Commission have reached an agreement that ends legal proceedings over the execution of the advance purchase agreement for the delivery of Vaxzevria. 

AstraZeneca and European Commission Reach Settlement Agreement Over COVID-19 Vaccine Supply

Thermo Fisher Scientific plans to expand its Nashville, Tenn., site by establishing a dedicated single-use technology manufacturing facility at the site, doubling capacity. 

Thermo Fisher to Establish Single-Use Technology Site in US

The US government has granted Thermo Fisher Scientific a $192.5 million contract that the company will use to expand domestic manufacturing for pipette tips.

Thermo Fisher Scientific to Expand Pipette Tip Manufacturing Under $192.5 Million Government Contract

Element’s acquisition of Impact Analytical expands their life sciences footprint in North America.

Supplier News